BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21170262)

  • 21. Dynamics of the subcellular localization of RalBP1/RLIP through the cell cycle: the role of targeting signals and of protein-protein interactions.
    Fillatre J; Delacour D; Van Hove L; Bagarre T; Houssin N; Soulika M; Veitia RA; Moreau J
    FASEB J; 2012 May; 26(5):2164-74. PubMed ID: 22319010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RalA is overactivated in medulloblastoma.
    Ginn KF; Fangman B; Terai K; Wise A; Ziazadeh D; Shah K; Gartrell R; Ricke B; Kimura K; Mathur S; Borrego-Diaz E; Farassati F
    J Neurooncol; 2016 Oct; 130(1):99-110. PubMed ID: 27566179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The RAL Enigma: Distinct Roles of RALA and RALB in Cancer.
    Richardson DS; Spehar JM; Han DT; Chakravarthy PA; Sizemore ST
    Cells; 2022 May; 11(10):. PubMed ID: 35626682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery and characterization of small molecules that target the GTPase Ral.
    Yan C; Liu D; Li L; Wempe MF; Guin S; Khanna M; Meier J; Hoffman B; Owens C; Wysoczynski CL; Nitz MD; Knabe WE; Ahmed M; Brautigan DL; Paschal BM; Schwartz MA; Jones DN; Ross D; Meroueh SO; Theodorescu D
    Nature; 2014 Nov; 515(7527):443-7. PubMed ID: 25219851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer.
    Male H; Patel V; Jacob MA; Borrego-Diaz E; Wang K; Young DA; Wise AL; Huang C; Van Veldhuizen P; O'Brien-Ladner A; Williamson SK; Taylor SA; Tawfik O; Esfandyari T; Farassati F
    Lung Cancer; 2012 Aug; 77(2):252-9. PubMed ID: 22498113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The RalB-RLIP76 complex reveals a novel mode of ral-effector interaction.
    Fenwick RB; Campbell LJ; Rajasekar K; Prasannan S; Nietlispach D; Camonis J; Owen D; Mott HR
    Structure; 2010 Aug; 18(8):985-95. PubMed ID: 20696399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1).
    Singhal SS; Singhal J; Yadav S; Dwivedi S; Boor PJ; Awasthi YC; Awasthi S
    Cancer Res; 2007 May; 67(9):4382-9. PubMed ID: 17483352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The epsin family of endocytic adaptors promotes fibrosarcoma migration and invasion.
    Coon BG; Burgner J; Camonis JH; Aguilar RC
    J Biol Chem; 2010 Oct; 285(43):33073-33081. PubMed ID: 20709745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different metastasis promotive potency of small G-proteins RalA and RalB in in vivo hamster tumor model.
    Rybko VA; Knizhnik AV; Komelkov AV; Aushev VN; Trukhanova LS; Tchevkina EM
    Cancer Cell Int; 2011 Jun; 11(1):22. PubMed ID: 21714887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulated RalBP1 binding to RalA and PSD-95 controls AMPA receptor endocytosis and LTD.
    Han K; Kim MH; Seeburg D; Seo J; Verpelli C; Han S; Chung HS; Ko J; Lee HW; Kim K; Heo WD; Meyer T; Kim H; Sala C; Choi SY; Sheng M; Kim E
    PLoS Biol; 2009 Sep; 7(9):e1000187. PubMed ID: 19823667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulation of micro-143-3p and BALBP1 contributes to the pathogenesis of the development of ovarian carcinoma.
    Zhang H; Li W
    Oncol Rep; 2016 Dec; 36(6):3605-3610. PubMed ID: 27748916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RalGPS2 is involved in tunneling nanotubes formation in 5637 bladder cancer cells.
    D'Aloia A; Berruti G; Costa B; Schiller C; Ambrosini R; Pastori V; Martegani E; Ceriani M
    Exp Cell Res; 2018 Jan; 362(2):349-361. PubMed ID: 29208460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coupling mitochondrial and cell division.
    Yamano K; Youle RJ
    Nat Cell Biol; 2011 Sep; 13(9):1026-7. PubMed ID: 21892144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone.
    Yin J; Pollock C; Tracy K; Chock M; Martin P; Oberst M; Kelly K
    Mol Cell Biol; 2007 Nov; 27(21):7538-50. PubMed ID: 17709381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RalA suppresses early stages of Ras-induced squamous cell carcinoma progression.
    Sowalsky AG; Alt-Holland A; Shamis Y; Garlick JA; Feig LA
    Oncogene; 2010 Jan; 29(1):45-55. PubMed ID: 19802010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation and involvement of Ral GTPases in colorectal cancer.
    Martin TD; Samuel JC; Routh ED; Der CJ; Yeh JJ
    Cancer Res; 2011 Jan; 71(1):206-15. PubMed ID: 21199803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The brain exocyst complex interacts with RalA in a GTP-dependent manner: identification of a novel mammalian Sec3 gene and a second Sec15 gene.
    Brymora A; Valova VA; Larsen MR; Roufogalis BD; Robinson PJ
    J Biol Chem; 2001 Aug; 276(32):29792-7. PubMed ID: 11406615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcellular localization of aquaporin 3 in prostate cancer is regulated by RalA.
    Chen Q; Zhu L; Zong H; Song X; Wang L; Wang X; Yang D; Wang J
    Oncol Rep; 2018 May; 39(5):2171-2177. PubMed ID: 29532894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ral GTPase-activating protein regulates the malignancy of pancreatic ductal adenocarcinoma.
    Yoshimachi S; Shirakawa R; Cao M; Trinh DA; Gao P; Sakata N; Miyazaki K; Goto K; Miura T; Ariake K; Maeda S; Masuda K; Ishida M; Ohtsuka H; Unno M; Horiuchi H
    Cancer Sci; 2021 Aug; 112(8):3064-3073. PubMed ID: 34009715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mass spectroscopic phosphoprotein mapping of Ral binding protein 1 (RalBP1/Rip1/RLIP76).
    Herlevsen MC; Theodorescu D
    Biochem Biophys Res Commun; 2007 Oct; 362(1):56-62. PubMed ID: 17706599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.